Related Experiment Video
Updated: May 14, 2026

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Longitudinal Surgical Aortic Valve Replacement Outcomes for Asymptomatic Severe Aortic Stenosis With Preserved
Maxwell C Braasch1, Levi Bonnell2, Mary A Siki1
1Division of Cardiothoracic Surgery, Department of Surgery, Washington University in St Louis, St Louis, Missouri.
Background:
Recent evidence supports early intervention in patients with asymptomatic aortic stenosis (AS) and normal ejection fraction. The study objective was to compare longitudinal surgical aortic valve replacement (SAVR) outcomes in asymptomatic vs symptomatic patients with normal left ventricular ejection fraction (LVEF).
Methods:
The Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database was leveraged to identify patients who underwent isolated SAVR for asymptomatic or symptomatic severe AS with LVEF ≥50% between July 2011 and December 2022. The cohort was linked to Centers for Medicare & Medicaid Services data. The primary outcome was risk-adjusted 10-year survival. Subgroup analysis evaluated long-term survival stratified by age, LVEF, and STS predicted risk of mortality (PROM).
Results:
A total of 17,683 patients with LVEF ≥50% underwent isolated SAVR; 16,284 (92.1%) were symptomatic and 1399 (7.9%) were asymptomatic. Compared with symptomatic patients, asymptomatic patients were younger (mean age, 74.2 vs 75.0 years; P < .001) and had lower STS PROM (1.9% ± 1.4% vs 2.5% ± 2.0%; P < .001). After risk adjustment, asymptomatic patients demonstrated superior 10-year survival compared with symptomatic patients (adjusted hazard ratio [aHR], 1.19 [95% CI, 1.09-1.29]). In subgroup analyses, long-term survival benefit was more pronounced in asymptomatic vs symptomatic patients aged ≥75 years (aHR, 1.24 [95% CI, 1.11-1.39]), LVEF ≥60% (aHR, 1.20 [95% CI, 1.08-1.34]), and STS PROM <2% (aHR, 1.17 [95% CI, 1.01-1.34]).
Conclusions:
In patients with severe AS and preserved LVEF, SAVR before symptom onset shows superior long-term survival. This study supports early SAVR in carefully selected patients with asymptomatic severe AS.
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis I: Introduction
